PRESTIGE CONSUMER HEALTHCARE (PBH)
US74112D1019 - Common Stock
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
PBH Crosses Below Key Moving Average Level
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily...
Prestige Consumer Healthcare Breaks Above 200-Day Moving Average - Bullish for PBH
Prestige unit Insight recalls antifungal due to carcinogen
Insight Pharmaceuticals, a unit of Prestige Consumer Healtrhcare (PBH) issues a nationwide recall of TING Athlete's Foot Spray due to carcinogen. Read more here.
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily...
Prestige Consumer Healthcare GAAP EPS of $1.07 in-line, revenue of $286.3M beats by $1.09M (NYSE:PBH)
Prestige Consumer Healthcare reports Q2 results: in-line GAAP EPS of $1.07, revenue of $286.3M beats by $1.09M, and reduced leverage ratio to 3.0x.
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter...
PBH Crosses Above Key Moving Average Level
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second...
Prestige Consumer Healthcare is Now Oversold (PBH)
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global...
Notable Two Hundred Day Moving Average Cross - PBH
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
Revenue of $279.3 Million in Q1, up 0.8% versus Prior Year and up 1.8% excluding Foreign CurrencyReduced Leverage Ratio to 3.2x at Quarter End and...
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first...
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the...